10x Genomics is trading at $79.48, down 4.95%, amid broader technology-market weakness; no company-specific announcement explaining the decline was identified.
- The Nasdaq Composite was down 1.30% pre-market, consistent with broader pressure, but this does not establish the precise cause of the stock’s move.
- Reuters reported Alphabet fell 10% after-hours and Nasdaq futures dropped 0.9% amid renewed AI-spending concerns.
- Third-quarter results are scheduled for November 5.